MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 130 filers reported holding MACROGENICS INC in Q4 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,511 | -21.9% | 57,835 | -10.4% | 0.00% | – |
| Q2 2023 | $345,267 | +40.7% | 64,536 | +88.5% | 0.00% | – |
| Q1 2023 | $245,479 | +7.1% | 34,237 | +0.3% | 0.00% | – |
| Q4 2022 | $229,120 | +94.2% | 34,146 | +0.1% | 0.00% | – |
| Q3 2022 | $118,000 | -98.6% | 34,110 | -92.6% | 0.00% | -100.0% |
| Q1 2019 | $8,259,000 | +41.6% | 459,335 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $5,834,000 | -40.8% | 459,335 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $9,848,000 | -0.6% | 459,335 | -4.2% | 0.01% | 0.0% |
| Q2 2018 | $9,904,000 | -17.9% | 479,615 | +0.0% | 0.01% | -16.7% |
| Q1 2018 | $12,064,000 | +32.4% | 479,500 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $9,111,000 | -1.8% | 479,500 | -4.5% | 0.00% | -20.0% |
| Q3 2017 | $9,275,000 | +5.5% | 501,900 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $8,788,000 | -19.5% | 501,900 | -14.5% | 0.00% | -33.3% |
| Q1 2017 | $10,920,000 | -9.0% | 587,100 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $12,000,000 | -33.0% | 587,100 | -2.0% | 0.01% | -33.3% |
| Q3 2016 | $17,910,000 | +10.8% | 598,800 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $16,162,000 | +44.9% | 598,800 | +0.6% | 0.01% | +50.0% |
| Q1 2016 | $11,156,000 | -39.5% | 595,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $18,427,000 | +39.2% | 595,000 | -3.7% | 0.01% | +28.6% |
| Q3 2015 | $13,238,000 | -52.0% | 618,000 | -14.9% | 0.01% | -46.2% |
| Q2 2015 | $27,570,000 | +21.0% | 726,100 | 0.0% | 0.01% | +30.0% |
| Q1 2015 | $22,778,000 | -4.1% | 726,100 | +7.2% | 0.01% | -9.1% |
| Q4 2014 | $23,753,000 | +124.0% | 677,300 | +33.5% | 0.01% | +120.0% |
| Q3 2014 | $10,603,000 | -10.3% | 507,300 | -6.7% | 0.01% | 0.0% |
| Q2 2014 | $11,819,000 | -8.9% | 543,900 | +16.6% | 0.01% | -16.7% |
| Q1 2014 | $12,980,000 | +20.3% | 466,400 | +18.5% | 0.01% | +20.0% |
| Q4 2013 | $10,794,000 | – | 393,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,200,000 | $40,656,000 | 9.26% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $19,854,000 | 5.17% |
| DAFNA Capital Management LLC | 154,200 | $2,850,000 | 1.77% |
| Mesirow Financial Investment Management, Inc. | 15,747 | $291,000 | 1.37% |
| BB BIOTECH AG | 2,400,412 | $44,360,000 | 1.23% |
| Aviva Holdings Ltd. | 115,914 | $2,142,000 | 1.11% |
| First Light Asset Management, LLC | 151,670 | $2,803,000 | 0.89% |
| Bellevue Group AG | 433,299 | $8,007,000 | 0.84% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,429,000 | 0.80% |
| Hood River Capital Management LLC | 588,799 | $10,881,000 | 0.69% |